Why Endpoint Protection Matters Immunology and inflammation (I&I) studies frequently rely on complex clinical assessments, composite disease activity scores, imaging evaluations, endoscopic findings, histopathology interpretations, and biomarker measurements to demonstrate treatment benefit. Unlike laboratory values that can be measured objectively, many efficacy endpoints in I&I trials depend on human assessment and interpretation, creating opportunities for […] The post Protecting the Primary Endpoint: Ensuring Data Integrity in Immunology & Inflammation Clinical Trials appeared first on Allucent .